Prson Gautam, PhD

Scientific Advisor: Dept. of Biomedicine and Translational Research

Dr. Prson Gautam received his MSc degree in Applied Biotechnology at the Uppsala University, Sweden, and completed his PhD at the Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Finland in Jan 2018. During his PhD he used chemical systems biology approach to study triple negative breast cancer with an aim to establish precision based therapeutic strategies under the supervision of Prof. Dr. Krister Wennerberg. Currently, he is working as a senior researcher in Prof. Dr. Tero Aittokallio’s group at FIMM, University of Helsinki. In addition, he is also working as global study/project manager at pharmaceutical company Bayer. In FIMM, he aims to identify drug or drug combinations against pancreatic and breast cancer, applying drug repurposing studies. Besides, he is also involved in multiple bioinformatics projects to develop machine learning based predictive models to predict drug/drug combination effects and biomarkers.  In Bayer, he is running/ managing first in human to phase 3 clinical trials. As a scientist, he has supervised several undergrad and grad students, published around 20 international research articles and also reviewed several research articles

  • Senior researcher, Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland, (December 2019-Until now)
  • Global study/project manager trainee, Bayer, Finland (August 2018-Until now)
  • Team Member, Research institute for Bioscience & Biotechnology (RIBB), Kathmandu, Nepal (December 2018-Until now)
  • Post-doctoral researcher, Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland (January 2018-November 2019)
xe88 apk